Initial treatment may involve daily injections, followed by a weekly or monthly maintenance schedule based on patient response
Heres how it works: Impacting Growth Factors: BPC-157 activates the JAK2 signaling pathway and enhances growth hormone receptor activity, particularly in tendon cells
However, certain special situations, such as immature blood-brain barrier (BBB) in infants, compromised BBB, high-dose exposure, small molecular weight, few aromatic amino acids, light hydrophobicity, light cationic properties, transport mechanisms, and indirect effects, can affect BBB transitions (Domenger et al
Nat Med 31 , 951962 (2025)
Cahn A, Wiviott SD, Mosenzon O, Murphy SA, Goodrich EL, Yanuv I, Rozenberg A, Wilding JPH, Leiter LA, Bhatt DL, et al